Latest News On HHS

Latest KFF Health News Stories

As Giant Hospitals Get Bigger, an Independent Doctor Feels the Pinch

KFF Health News Original

Independent medical practices keep closing as doctors join behemoth hospital groups or leave the field. Research suggests that’s bad news for patients. Studies repeatedly conclude that consolidation in the health care industry is driving up costs while showing no clear evidence of improved care.

Nursing Home Surprise: Advantage Plans May Shorten Stays to Less Time Than Medicare Covers

KFF Health News Original

Private Medicare Advantage health plans are increasingly ending coverage for skilled nursing or rehab services before medical providers think patients are healthy enough to go home, doctors and patient advocates say.

Newborns Get Routine Heel Blood Tests, but Should States Keep Those Samples?

KFF Health News Original

Shortly after birth, babies are pricked in the heel so their blood can be tested for life-threatening conditions. States generally save leftover blood from those samples, and parents and privacy experts are concerned that information could be used without consent years later.

Meet Mary Wakefield, the Nurse Administrator Tasked With Revamping the CDC

KFF Health News Original

Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention, has tapped Mary Wakefield to help “reset” the agency after its public failures handling the covid pandemic. Those who know Wakefield say her high standards and problem-solving skills make her a good fit for the job.

Patients and Doctors Trapped in a Gray Zone When Abortion Laws and Emergency Care Mandate Conflict

KFF Health News Original

Since the U.S. Supreme Court overturned Roe v. Wade in June, ER doctors say they — and their patients — are trapped between state anti-abortion laws and the federal law requiring that care be delivered in emergency situations. Women’s lives hang in the balance.

KHN’s ‘What the Health?’: Kansas Makes a Statement

KFF Health News Original

In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.

KHN’s ‘What the Health?’: Life After ‘Roe’ Is … Confusing

KFF Health News Original

A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response

KFF Health News Original

Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.

Buy and Bust: When Private Equity Comes for Rural Hospitals

KFF Health News Original

Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.

KHN’s ‘What the Health?’: Washington’s Slow Churn

KFF Health News Original

Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but it’s hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Michelle Andrews, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.

Why So Slow? Legislators Take on Insurers’ Delays in Approving Prescribed Treatments

KFF Health News Original

Insurers say prior authorization requirements are intended to reduce wasteful and inappropriate health care spending. But they can baffle patients waiting for approval. And doctors say that insurers have yet to follow through on commitments to improve the process.

Is Paxlovid, the Covid Pill, Reaching Those Who Most Need It? The Government Won’t Say

KFF Health News Original

Many public health workers are unable to see how many doses of Pfizer’s antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.

At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills

KFF Health News Original

Prosecutors say opioid-seeking patients drove hours to get their prescriptions filled in Celina, Tennessee, where pharmacies ignored signs of substance misuse and paid cash — or “monkey bucks” — to keep customers coming back.

It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.

KFF Health News Original

At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.